Search for other works by this author on: ...

1Fred Hutchinson Cancer Center, Seattle, WA.

Search for other works by this author on: ...

Breast cancer is the second most common cancer globally. Most deaths from breast cancer are due to metastatic disease which often follows long periods of clinical dormancy. Understanding the ...

Jamie E. Medina; Akshaya V. Annapragada; Pien Lof; Sarah Short; Adrianna L. Bartolomucci; Dimitrios Mathios; Shashikant Koul; Noushin Niknafs; Michaël Noë ...

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons ...

1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. *Corresponding Author: Jaleh Fallah, U.S. Center for Drug Evaluation and Research, Office of New ...

Bristol Myers Squibb (BMS) faces a $6.7 billion lawsuit alleging that the company purposely delayed approval of Celgene-developed drugs to avoid paying Celgene shareholders owning contingent value ...

1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. 2Department of Medicine, Weill Cornell Medical College, New York, New York. *Corresponding Author: Claire F.

1Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. 9Early Drug Development Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York ...

Deep learning (DL) delineation of the prostate gland and prostate cancer detection on PSMA PET/CT: results from prospective, randomised, multi-centre pro-PSMA trial ...

1Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China. 2China-US (Henan) Hormel Cancer Institute, Zhengzhou, China. 3Tianjian Laboratory of Advanced ...